Pharmacotherapy of Androgenetic Alopecia – A Literature Review

    Marcin Tyszkiewicz, Kinga Pożarowska, Agata Rosińska, Maciej Orczykowski
    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Studysummary This review discusses various pharmacotherapies for androgenetic alopecia, concluding that combination therapies may offer more effective treatment, though more research on alternative preparations is needed. Our plain-language summary of this paper — not a Tressless recommendation.
    The review examines the pharmacotherapy of androgenetic alopecia, focusing on the effectiveness and safety of FDA-approved treatments like oral finasteride (1 mg) and topical minoxidil (2% or 5%). It also considers other promising treatments such as topical finasteride (0.1%) and oral dutasteride, which need more research. The authors propose that combination therapy with multiple preparations can enhance results and reduce systemic side effects by using topical treatments.
    Discuss this study in the Community →